CGPA Canadian Generic Pharmaceutical Associaton

The Canadian Generic Pharmaceutical Association (CGPA) represents manufacturers and distributors of finished generic pharmaceutical products, manufacturers and distributors of active pharmaceutical chemicals, and suppliers of other goods and services to the generic pharmaceutical industry.

For more than 50 years, Canada’s generic pharmaceutical industry has played a vital role in the country’s health-care system and its economy by providing safe, effective, proven alternatives to more expensive brand-name medicines.

Jobs

The generic pharmaceutical industry employs more than 11, 000 Canadians in well-paid, highly skilled jobs in research and development, manufacturing and other operations.

Innovation

The generic pharmaceutical industry spends approximately $450-million annually on research and development in Canada.

Generic pharmaceutical companies in Canada invest approximately 15% of sales in research and development.

Exports

Canada’s generic drug industry generates 40% of its sales volume from exporting made-in-Canada pharmaceuticals, primarily to the United States.

Manufacturing

In terms of who is doing what in Canada, most brand-name drugs sold in Canada are shipped into the country. Almost all generic drugs sold in Canada are made right here. In fact, the majority of the pharmaceutical manufacturing capacity that exists in Canada is generic.

Related posts:

1. GPhA Generic Pharmaceutical Association The Generic Pharmaceutical Association (GPhA) represents the manufacturers and distributors...
2. When can a generic drug be produced? When a pharmaceutical company first markets a drug, it is...
3. European generic medicines association The EGA is the official representative body of the European...
4. Generic drugs economics Generic drugs can save patients and insurance companies substantial costs....